# Empery Digital Inc.: financial statements, quarterly EMPD · Nasdaq · CIK 1829794 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/empd.md) · [Financials](/companies/empd/financials.md) · [Filings](/companies/empd/filings.md) · [Insiders](/companies/empd/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/empd/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.5](/filings/0001683168-24-007859.md) | [1.1 d](/filings/0001683168-25-002047.md) | [1.0](/filings/0001683168-25-003351.md) | [0.9](/filings/0001683168-25-005920.md) | [1.1](/filings/0001683168-25-008152.md) | [0.9 d](/filings/0001683168-26-002333.md) | [0.5](/filings/0001683168-26-003608.md) | [0.2](/filings/0001683168-26-006099.md) | [0.2](/filings/0001683168-25-008152.md) | [(0.7) d](/filings/0001683168-26-002333.md) | [0.2](/filings/0001683168-26-003608.md) | [0.1](/filings/0001683168-26-006099.md) | | Cost of revenue | $m | [3.5](/filings/0001683168-24-007859.md) | [6.3 d](/filings/0001683168-25-002047.md) | [1.6](/filings/0001683168-25-003351.md) | [3.1](/filings/0001683168-25-005920.md) | [10.3](/filings/0001683168-25-008152.md) | [3.0 d](/filings/0001683168-26-002333.md) | [0.5](/filings/0001683168-26-003608.md) | [0.4](/filings/0001683168-26-006099.md) | [0.3](/filings/0001683168-25-008152.md) | [(0.6) d](/filings/0001683168-26-002333.md) | [0.2](/filings/0001683168-26-003608.md) | [0.1](/filings/0001683168-26-006099.md) | | Gross profit | $m | [(3.1)](/filings/0001683168-24-007859.md) | [(5.2) d](/filings/0001683168-25-002047.md) | [(0.6)](/filings/0001683168-25-003351.md) | [(2.2)](/filings/0001683168-25-005920.md) | [(9.2)](/filings/0001683168-25-008152.md) | [(2.0) d](/filings/0001683168-26-002333.md) | [(0.0)](/filings/0001683168-26-003608.md) | [(0.2)](/filings/0001683168-26-006099.md) | [(0.1)](/filings/0001683168-25-008152.md) | [(0.1) d](/filings/0001683168-26-002333.md) | [0.1](/filings/0001683168-26-003608.md) | [(0.1)](/filings/0001683168-26-006099.md) | | Operating income | $m | [(9.5)](/filings/0001683168-24-007859.md) | [(9.9) d](/filings/0001683168-25-002047.md) | [(4.2)](/filings/0001683168-25-003351.md) | [(5.5)](/filings/0001683168-25-005920.md) | [(12.1)](/filings/0001683168-25-008152.md) | [(3.7) d](/filings/0001683168-26-002333.md) | [(2.1)](/filings/0001683168-26-003608.md) | [(3.5)](/filings/0001683168-26-006099.md) | [(34.5)](/filings/0001683168-25-008152.md) | [(113) d](/filings/0001683168-26-002333.md) | [(83.3)](/filings/0001683168-26-003608.md) | [(42.1)](/filings/0001683168-26-006099.md) | | Interest expense | $m | [1.1](/filings/0001683168-23-007575.md) | [0.5 d](/filings/0001683168-24-001823.md) | [0.3](/filings/0001683168-24-003059.md) | [0.2](/filings/0001683168-25-005920.md) | [0.1](/filings/0001683168-25-008152.md) | [0.0 d](/filings/0001683168-26-002333.md) | [0.1](/filings/0001683168-26-003608.md) | [0.1](/filings/0001683168-26-006099.md) | [0.4](/filings/0001683168-25-008152.md) | [1.7 d](/filings/0001683168-26-002333.md) | [2.1](/filings/0001683168-26-003608.md) | [1.1](/filings/0001683168-26-006099.md) | | Income tax | $m | [0.0](/filings/0001683168-24-007859.md) | [0.0 d](/filings/0001683168-25-002047.md) | [0.0](/filings/0001683168-25-003351.md) | [0.0](/filings/0001683168-25-005920.md) | [0.0](/filings/0001683168-25-008152.md) | [0.0 d](/filings/0001683168-26-002333.md) | [0.0](/filings/0001683168-26-003608.md) | [0.0](/filings/0001683168-26-006099.md) | [(5.4)](/filings/0001683168-26-002333.md) | [0.0 d](/filings/0001683168-26-002333.md) | [0.0](/filings/0001683168-26-003608.md) | [0.0](/filings/0001683168-26-006099.md) | | Net income | $m | [(11.3)](/filings/0001683168-24-007859.md) | [(3.4) d](/filings/0001683168-25-002047.md) | [(26.0)](/filings/0001683168-25-003351.md) | [(0.6)](/filings/0001683168-25-005920.md) | [(13.6)](/filings/0001683168-25-008152.md) | [(5.2) d](/filings/0001683168-26-002333.md) | [(2.5)](/filings/0001683168-26-003608.md) | [(3.9)](/filings/0001683168-26-006099.md) | [(29.2)](/filings/0001683168-26-002333.md) | [(115) d](/filings/0001683168-26-002333.md) | [(85.4)](/filings/0001683168-26-003608.md) | [(43.0)](/filings/0001683168-26-006099.md) | | Diluted EPS | $ per share | [(66245.01)](/filings/0001683168-24-007859.md) | not reported | [(2615.00)](/filings/0001683168-25-003351.md) | [(96.59)](/filings/0001683168-25-005920.md) | [(191.46)](/filings/0001683168-25-008152.md) | not reported | [(7.27)](/filings/0001683168-26-003608.md) | [(7.57)](/filings/0001683168-26-006099.md) | [(0.80)](/filings/0001683168-26-002333.md) | not reported | [(2.59)](/filings/0001683168-26-003608.md) | [(1.53)](/filings/0001683168-26-006099.md) | | Basic EPS | $ per share | [(66245.01)](/filings/0001683168-24-007859.md) | not reported | [(2615.00)](/filings/0001683168-25-003351.md) | [(96.59)](/filings/0001683168-25-005920.md) | [(191.46)](/filings/0001683168-25-008152.md) | not reported | [(7.27)](/filings/0001683168-26-003608.md) | [(7.57)](/filings/0001683168-26-006099.md) | [(0.80)](/filings/0001683168-26-002333.md) | not reported | [(2.59)](/filings/0001683168-26-003608.md) | [(1.53)](/filings/0001683168-26-006099.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [2.4](/filings/0001683168-23-007575.md) | [8.0](/filings/0001683168-25-002047.md) | [3.6](/filings/0001683168-24-003059.md) | [2.1](/filings/0001683168-24-005280.md) | [5.8](/filings/0001683168-24-007859.md) | [2.2](/filings/0001683168-26-002333.md) | not reported | [11.8](/filings/0001683168-25-005920.md) | [18.8](/filings/0001683168-25-008152.md) | [9.0](/filings/0001683168-26-006099.md) | [5.7](/filings/0001683168-26-003608.md) | [3.6](/filings/0001683168-26-006099.md) | | Current assets | $m | [13.4](/filings/0001683168-23-007575.md) | [19.5](/filings/0001683168-25-002047.md) | [15.1](/filings/0001683168-24-003059.md) | [14.0](/filings/0001683168-24-005280.md) | [8.7](/filings/0001683168-24-007859.md) | [5.1](/filings/0001683168-26-002333.md) | [20.5](/filings/0001683168-25-003351.md) | [16.5](/filings/0001683168-25-005920.md) | [25.2](/filings/0001683168-25-008152.md) | [14.3](/filings/0001683168-26-006099.md) | [12.8](/filings/0001683168-26-003608.md) | [5.0](/filings/0001683168-26-006099.md) | | Total assets | $m | [16.1](/filings/0001683168-23-007575.md) | [22.1](/filings/0001683168-25-002047.md) | [17.4](/filings/0001683168-24-003059.md) | [15.8](/filings/0001683168-24-005280.md) | [10.0](/filings/0001683168-24-007859.md) | [6.2](/filings/0001683168-26-002333.md) | [21.7](/filings/0001683168-25-003351.md) | [17.9](/filings/0001683168-25-005920.md) | [492](/filings/0001683168-25-008152.md) | [372](/filings/0001683168-26-006099.md) | [218](/filings/0001683168-26-003608.md) | [180](/filings/0001683168-26-006099.md) | | Current liabilities | $m | [36.2](/filings/0001683168-23-007575.md) | [40.9](/filings/0001683168-25-002047.md) | [12.9](/filings/0001683168-24-003059.md) | [6.6](/filings/0001683168-24-005280.md) | [4.2](/filings/0001683168-24-007859.md) | [4.6](/filings/0001683168-26-002333.md) | [4.0](/filings/0001683168-25-003351.md) | [3.6](/filings/0001683168-25-005920.md) | [54.1](/filings/0001683168-25-008152.md) | [52.8](/filings/0001683168-26-006099.md) | [6.3](/filings/0001683168-26-003608.md) | [10.7](/filings/0001683168-26-006099.md) | | Total liabilities | $m | [37.1](/filings/0001683168-23-007575.md) | [41.8](/filings/0001683168-25-002047.md) | [13.6](/filings/0001683168-24-003059.md) | [7.9](/filings/0001683168-24-005280.md) | [4.9](/filings/0001683168-24-007859.md) | [6.2](/filings/0001683168-26-002333.md) | [5.0](/filings/0001683168-25-003351.md) | [4.1](/filings/0001683168-25-005920.md) | [54.6](/filings/0001683168-25-008152.md) | [103](/filings/0001683168-26-006099.md) | [51.7](/filings/0001683168-26-003608.md) | [66.1](/filings/0001683168-26-006099.md) | | Long-term debt | $m | [0.1](/filings/0001683168-23-007575.md) | [0.1](/filings/0001683168-24-001823.md) | [0.1](/filings/0001683168-24-003059.md) | [0.1](/filings/0001683168-24-005280.md) | [0.0](/filings/0001683168-24-007859.md) | [0.0](/filings/0001683168-26-002333.md) | [0.0](/filings/0001683168-25-003351.md) | [0.0](/filings/0001683168-25-005920.md) | [0.0](/filings/0001683168-25-008152.md) | [49.9](/filings/0001683168-26-006099.md) | [45.0](/filings/0001683168-26-003608.md) | [55.0](/filings/0001683168-26-006099.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001683168-26-002333.md) | not reported | not reported | [49.9](/filings/0001683168-25-008152.md) | [49.9](/filings/0001683168-26-006099.md) | [0.0](/filings/0001683168-26-003608.md) | [0.0](/filings/0001683168-26-006099.md) | | Shareholders' equity | $m | [(20.9)](/filings/0001683168-24-007859.md) | [(19.6)](/filings/0001683168-26-002333.md) | [3.8](/filings/0001683168-25-003351.md) | [7.9](/filings/0001683168-25-005920.md) | [5.1](/filings/0001683168-25-008152.md) | [0.0](/filings/0001683168-26-006099.md) | [16.7](/filings/0001683168-26-003608.md) | [13.8](/filings/0001683168-26-006099.md) | [438](/filings/0001683168-25-008152.md) | [269](/filings/0001683168-26-006099.md) | [166](/filings/0001683168-26-003608.md) | [113](/filings/0001683168-26-006099.md) | - Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(6.2) d](/filings/0001683168-24-007859.md) | [(12.8) d](/filings/0001683168-25-002047.md) | [(4.5)](/filings/0001683168-25-003351.md) | [(3.7) d](/filings/0001683168-25-005920.md) | [(4.1) d](/filings/0001683168-25-008152.md) | [(3.8) d](/filings/0001683168-26-002333.md) | [(3.6)](/filings/0001683168-26-003608.md) | [(3.7) d](/filings/0001683168-26-006099.md) | [(7.6) d](/filings/0001683168-25-008152.md) | [(3.0) d](/filings/0001683168-26-002333.md) | [(3.5)](/filings/0001683168-26-003608.md) | [(6.9) d](/filings/0001683168-26-006099.md) | | Capital expenditure | $m | [0.4 d](/filings/0001683168-24-007859.md) | [0.1 d](/filings/0001683168-25-002047.md) | [0.1](/filings/0001683168-25-003351.md) | [0.1 d](/filings/0001683168-25-005920.md) | [0.0 d](/filings/0001683168-25-008152.md) | [0.0 d](/filings/0001683168-26-002333.md) | [0.2](/filings/0001683168-26-003608.md) | [0.0 d](/filings/0001683168-26-006099.md) | [(0.0) d](/filings/0001683168-25-008152.md) | [0.0 d](/filings/0001683168-26-002333.md) | [0.0](/filings/0001683168-26-003608.md) | [0.0 d](/filings/0001683168-26-006099.md) | | Share repurchases | $m | not reported | not reported | [0.0](/filings/0001683168-25-003351.md) | [0.0 d](/filings/0001683168-25-005920.md) | [0.0 d](/filings/0001683168-25-008152.md) | [0.0 d](/filings/0001683168-26-002333.md) | [0.4](/filings/0001683168-26-003608.md) | [0.1 d](/filings/0001683168-26-006099.md) | [38.9 d](/filings/0001683168-25-008152.md) | [56.9 d](/filings/0001683168-26-002333.md) | [44.2](/filings/0001683168-26-003608.md) | [9.8 d](/filings/0001683168-26-006099.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [24.3](/filings/0001683168-22-007482.md) | [24.5](/filings/0001683168-23-003032.md) | [0.0](/filings/0001683168-24-005280.md) | [0.0](/filings/0001683168-24-007859.md) | [0.0](/filings/0001683168-25-003351.md) | [0.0](/filings/0001683168-25-005920.md) | [0.1](/filings/0001683168-25-008152.md) | [0.3](/filings/0001683168-26-003608.md) | [0.5](/filings/0001683168-26-006099.md) | [36.1](/filings/0001683168-25-008152.md) | [33.0](/filings/0001683168-26-003608.md) | [28.1](/filings/0001683168-26-006099.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 28,110,111 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001683168-26-006099.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.